Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology.

Arrhythmia Wolf-Parkinson-White athlete atrial fibrillation sports cardiology supraventricular tachycardia

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
20 12 2021
Historique:
received: 17 04 2020
accepted: 18 04 2020
pubmed: 1 7 2020
medline: 5 4 2022
entrez: 30 6 2020
Statut: ppublish

Résumé

Symptoms attributable to arrhythmias are frequently encountered in clinical practice. Cardiologists and sport physicians are required to identify high-risk individuals harbouring such conditions and provide appropriate advice regarding participation in regular exercise programmes and competitive sport. The three aspects that need to be considered are: (a) the risk of life-threatening arrhythmias by participating in sports; (b) control of symptoms due to arrhythmias that are not life-threatening but may hamper performance and/or reduce the quality of life; and (c) the impact of sports on the natural progression of the underlying arrhythmogenic condition. In many cases, there is no unequivocal answer to each aspect and therefore an open discussion with the athlete is necessary, in order to reach a balanced decision. In 2006 the Sports Cardiology and Exercise Section of the European Association of Preventive Cardiology published recommendations for participation in leisure-time physical activity and competitive sport in individuals with arrhythmias and potentially arrhythmogenic conditions. More than a decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of these conditions. The present document presents a combined effort by the Sports Cardiology and Exercise Section of the European Association of Preventive Cardiology and the European Heart Rhythm Association to offer a comprehensive overview of the most updated recommendations for practising cardiologists and sport physicians managing athletes with supraventricular arrhythmias, and provides pragmatic advice for safe participation in recreational physical activities, as well as competitive sport at amateur and professional level. A companion text on recommendations in athletes with ventricular arrhythmias, inherited arrhythmogenic conditions, pacemakers and implantable defibrillators is published as Part 2 in Europace.

Identifiants

pubmed: 32597206
doi: 10.1177/2047487320925635
pii: 6145723
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1539-1551

Investigateurs

Frank R Heinzel (FR)
Christian Veltmann (C)
Katja E Odening (KE)
Leif Hendrik Boldt (LH)
Anne Wim (A)
Carlo Napolitano (C)
Constantinos Davos (C)
Massimo Piepoli (M)
Alessandro Biffi (A)
Frank van Buuren (F)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Hein Heidbuchel (H)

Department of Cardiology, University Hospital Antwerp, Belgium.

Paolo E Adami (PE)

Italian National Olympic Committee, Institute of Sport Medicine and Science, Italy.

Matthias Antz (M)

Department of Electrophysiology, Hospital Braunschweig, Germany.

Frieder Braunschweig (F)

Heart and Vascular Theme, Karolinska University Hospital, Sweden.

Pietro Delise (P)

Peschiera del Garda, Italy.

Daniel Scherr (D)

Department of Medicine, Medical University of Graz, Austria.

Erik E Solberg (EE)

Diakonhjemmet Hospital, Department of Medicine, Norway.

Matthias Wilhelm (M)

Department of Cardiology, Bern University Hospital, Switzerland.

Antonio Pelliccia (A)

Italian National Olympic Committee, Institute of Sport Medicine and Science, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH